BMN 111 (vosoritide) Improves Growth Velocity in Children With Achondroplasia in Phase 2 Study
Go back to BMN 111 (vosoritide) Improves Growth Velocity in Children With Achondroplasia in Phase 2 Study| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 63.61 -0.45 (0.7%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $64.06 | 52 Week High | $108.96 | |||
| Open | $64.34 | 52 Week Low | $62.12 | |||
| Day High | $64.60 | P/E | N/A | |||
| Day Low | $63.39 | EPS | $-1.27 | |||
| Volume | 129,305 | |||||
| BANCO SANTANDER S.A. (NYSE: SAN) | Delayed: 14.61 -0.01 (0.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.62 | 52 Week High | $5.58 | |||
| Open | $14.68 | 52 Week Low | $3.60 | |||
| Day High | $14.71 | P/E | N/A | |||
| Day Low | $14.61 | EPS | $0.00 | |||
| Volume | 700,978 | |||||
| SANOFI (NASDAQ: SNY) | Delayed: 42.16 -0.34 (0.8%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $42.50 | 52 Week High | $44.76 | |||
| Open | $42.34 | 52 Week Low | $36.81 | |||
| Day High | $42.38 | P/E | N/A | |||
| Day Low | $42.03 | EPS | $0.00 | |||
| Volume | 357,341 | |||||

